Mirela Hendel

Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach

Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz et al. · Cardiovascular Diabetology · 2022 · 92 citations · Full text

Medicine, Cardiology, Clinical Sciences +15

Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia Diabetes-Heart Project

Hanna Kwiendacz, Bi Huang, Oliwia Janota et al. · Cardiovascular Diabetology · 2025 · 29 citations · Full text

Computing, Cardiology, Health Informatics +17

Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Katarzyna Sedlaczek et al. · Oxidative Medicine and Cellular Longevity · 2021 · 22 citations · Full text

Medicine, Internal Medicine, Pharmacology +15

Machine Learning Identifies Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Diabetes Mellitus

Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik et al. · The Journal of Clinical Endocrinology & Metabolism · 2024 · 17 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project

Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik et al. · Cardiovascular Diabetology · 2023 · 12 citations · Full text

Medicine, Cardiology, Computer Science +17